Dermal Cooling System for Skin Conditions
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot have used Accutane in the past 6 months.
What data supports the effectiveness of the Dermal Cooling System treatment for skin conditions?
Is the Dermal Cooling System generally safe for use in humans?
How does the Dermal Cooling System treatment differ from other treatments for skin conditions?
What is the purpose of this trial?
This trial is testing a device called the Dermal Cooling System, which cools the skin. It aims to see if this can improve how the skin looks and feels for people with common skin conditions. Cooling the skin may help by reducing inflammation and redness.
Research Team
Kristine Tatsutani, PhD
Principal Investigator
R2 Technologies
Eligibility Criteria
Adults over 18 with common skin conditions like psoriasis, dermatitis, acne, rosacea, and melasma can join this trial. They must be willing to avoid sun exposure on the treated area or use SPF 50 sunscreen if needed and not participate in other skin treatments during the study. Pregnant women, recent mothers, those with a history of melanoma or adverse reactions to cold are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive treatment with the Dermal Cooling System to evaluate cosmetic and physical symptom improvements
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Dermal Cooling System
Find a Clinic Near You
Who Is Running the Clinical Trial?
R2 Dermatology
Lead Sponsor